The end of the pandemic

Monday, 16 Nov, 2020

Western politicians have faulted China for initial delays in providing information as the coronavirus spread around the world.

Besides its agreements with Moderna and Arcturus, Israel has inked a deal with Italian biotech firm ReiThera to supply a vaccine if and when one is developed, and is in talks with Russian Federation to purchase a vaccine that country is developing.

Pfizer and its German partner, BioNTech, have announced that their COVID-19 vaccine appears to be more than 90 percent effective against the disease. The preliminary finding spurred a global stock rally and put the companies at the head of the pack in the race for the vaccine. Russian Federation was the first one to cut corners and recognize their vaccine prior to the completion of the Phase 3 testing.

The company, which is developing the mRNA-based vaccine candidate mRNA-1273, said that it has seen a "significant" increase in the rate of COVID-19 case identification across its trial sites in the United States over the last week.

Responding to another query on vaccine administration, he said, "We are in a position to not only augment and strengthen, but also to add to our cold chain capabilities".

The world has got itchy feet from the news of the vaccine, with millions hoping it will bring an end to the hellish reality of living with COVID-19. But what about the rest of the world, especially families in poorer countries? The virus that causes COVID-19 uses a special key called M-spike protein to enter human cells. "I think that's reasonable", Corey said.

Azra Behlim, the senior director of pharmacy sourcing and program services at Vizient, said it would likely be even more complicated to keep the vaccine in a stable temperature when distributing it in rural communities. "Samples have not been given".

DOUCLEFF: It nearly seems like rich countries are hoarding doses. Why?

The vaccine needs approval from regulators - and they will only grant that if they're happy the jab is safe and works well.

"During the pandemic stage, our COVID-19 vaccine contract is with the federal government and we'll be providing doses according to their designated vaccination locations", Pfizer added.

"The issue is the lack of transparency", he said.

While the government is making sure that Canadians are looked after, they are also committed to helping others across the globe.

Pfizer didn't report any serious safety concerns from the trial. Monitoring of the participants is ongoing, the ministry said.

Additionally, different health departments across that country have already asked the House of Congress for at least $8.4 billion more for a timely, comprehensive, and equitable vaccine distribution campaign. Elderly care facilities and health care providers will be the first to be offered the vaccine, according to USA officials.

"It's still too early to say that the USA has won the race", he said.

In addition to the improvised packaging, Pfizer plans to track the vaccine's temperature in transit. The only freezers that can reach such temperature are located in the research facilities and are very rare in hospitals.

Even China is jumping on board.

Challenges with the storage and transport of the vaccine, which must be kept at minus 70 degrees Celsius, will mean GP surgeries and pharmacies are unlikely to be able to store the vaccine.

"There has been a lot of preparatory work going on since March", she said.

He says he's confident that transmission between people will be reduced by perhaps 50% through a highly effective vaccine. "Cooperation will be hard given current levels of trust", said Mr Biren Nanda, a former Indian ambassador who spent a decade in China.